Abstract
Long-term acetyl-L-carnitine (ALCAR) administration prevents the development of escape deficit produced by acute exposure to unavoidable stress. However, it does not revert the escape deficit sustained by chronic stress exposure. Rats exposed to chronic stress show a low dopamine (DA) output in the nucleus accumbens shell (NAcS) and do not acquire an appetitive behavior sustained by the earning of vanilla sugar (VS) made contingent on the choice of one of the two divergent arms of a Y-maze (VS-sustained appetitive behavior, VAB), while control rats consistently do. The present study shows that ALCAR treatment in rats exposed to a 7-day stress protocol prevented a decrease in DA output in the NAcS and medial prefrontal cortex (mPFC) of rats, and that it strengthened the DA response to VS consummation in the same two areas. Moreover, rats treated with long-term ALCAR or exposed to chronic stress while treated with ALCAR acquired VAB as efficiently as control rats. Moreover, VAB acquisition in stressed rats treated with ALCAR coincided with the reversal of the deficits in escape and in dopaminergic transmission in the NAcS. Thus, repeated ALCAR treatment preserved the DA response to VS in chronically stressed rats and this effect appeared to be predictive of the rat's competence to acquire VAB.
Similar content being viewed by others
INTRODUCTION
L-Carnitine has been described as a conditionally essential nutrient for humans required for the transport of long-chain fatty acids into the mitochondria. It also facilitates the removal, from the mitochondria, of excess short- and medium-chain fatty acids that accumulate during metabolism (Liu et al, 2002). Acetyl-L-carnitine (ALCAR) is the acetyl ester of carnitine, and both ALCAR and carnitine play a crucial regulatory role in fatty acid oxidation (Fritz, 1963; Bieber, 1988). Carnitine and ALCAR affect other cellular functions, including maintenance of key proteins and lipids of the mitochondria at sufficient levels and proper membrane orientation, for maximum energy production (Liu et al, 2002). ALCAR, like L-carnitine, is present in high concentration in the brain. ALCAR is more widely used than L-carnitine in animal research and clinical trials because, in aging or in conditions of disease, ALCAR is better absorbed and it crosses the blood–brain barrier more efficiently than L-carnitine (Kidd, 1999). Moreover, at the cellular level, ALCAR seems to be the active molecule in some metabolic pathways (Cha and Sachan, 1995; Swamy-Mruthinti and Carter, 1999). Several in vitro and in vivo studies have indicated that ALCAR is involved in different aspects of neuronal activity and a thorough review of its CNS action has been published (Calvani and Carta, 1991). ALCAR may prevent some of the neurochemical sequelae of stress exposure, as repeated ALCAR treatment prevents the stress-induced decrease in nerve growth factor binding in rat brain (Foreman et al, 1995), and it counteracts the increase in β-endorphine induced by repeated exposure to stress (Bidzinska et al, 1993). ALCAR improves the feedback control of hypothalamus–pituitary–adrenal axis response to stress, at least in aged rats (Angelucci and Ramacci, 1989;Patacchioli et al, 1989).
We have shown that in rats a 7-day ALCAR treatment produces a steady increase in dopamine (DA) and serotonin (5-HT) output in the nucleus accumbens shell (NAcS), and it prevents the development of the avoidance deficit induced by exposure to acute unavoidable stress (Tolu et al, 2002). Antidepressant drugs, such as imipramine, fluoxetine, and clomipramine, show a similar preventive effect on the development of stress-induced behavioral sequelae (Gambarana et al, 2001). Moreover, they also revert a condition of chronic escape deficit sustained by repeated stress exposure (Gambarana et al, 2001), and we consider this reversal to be crucial to the definition of antidepressant activity. ALCAR administered daily for 3 weeks to rats exposed to chronic stress failed to modify the escape deficit condition (Tolu et al, 2002); thus, it cannot be defined as an antidepressant. The failure of ALCAR to counteract the effect of chronic stress on avoidance indicates that a steadily increased DA and 5-HT output in the NAcS is not sufficient for preventing the development of avoidance deficit.
Chronic stress exposure not only induces an avoidance deficit, but it also disrupts the acquisition of an appetitive behavior sustained by a highly palatable food (vanilla sugar, VS; sustained appetitive behavior, VAB) in rats fed ad libitum (Ghiglieri et al, 1997). Moreover, it decreases DA and 5-HT output in the medial prefrontal cortex (mPFC) and NAcS (Gambarana et al, 1999a; Mangiavacchi et al, 2001). However, no apparent correlation exists between the stress-induced behavioral modifications and these neurochemical effects. In fact, rats that have acquired VAB and are then exposed to chronic stress develop an avoidance deficit while retaining VAB (Ghiglieri et al, 1997); moreover, they show a DA output in the NAcS similar to that of control rats, and higher than that of chronically stressed rats (Masi et al, 2001). Furthermore, long-term treatment with lithium induces an avoidance deficit and a significant decrease in DA output in the NAcS (Gambarana et al, 1999b), but it does not interfere with VAB acquisition (Masi et al, 2000). Thus, no correlation can be demonstrated between basal DA output and VAB acquisition, as both long-term stress exposure and lithium treatment significantly reduce basal DA output in mesolimbic areas (Gambarana et al, 1999a,1999b; Mangiavacchi et al, 2001), but only lithium-treated rats maintain the competence to acquire VAB (Masi et al, 2000). However, satiated rats fed a palatable food show an increased DA release in the NAcS (Martel and Fantino, 1996; Ghiglieri et al, 1997) and in the mPFC, although rapid habituation to this effect selectively develops in the NAcS (Bassareo and Di Chiara, 1997, 1999a). Thus, we hypothesized that the acute dopaminergic response to VS consumption in the NAcS and/or mPFC could be predictive of the capacity of satiated rats to learn VAB, and ALCAR treatment seemed to be a useful tool for testing this hypothesis. In order to further investigate the relation between DA output in mesolimbic areas and the response to noxious or pleasurable stimuli in rats exposed to unavoidable stress, we studied whether:
-
repeated ALCAR administration, which by it self increases DA output, would counteract the effect of repeated exposure to unavoidable stress on DA output in the NAcS and mPFC;
-
rats exposed to unavoidable stress and treated or not treated with ALCAR would show a dopaminergic response to palatable food consumption;
-
repeated ALCAR administration would sustain the ability to learn an appetitive behavior in stressed rats.
METHODS
Animals
Experiments were carried out on male Sprague–Dawley rats (Charles River, Calco, Italy) weighing 125–150 g at their arrival in the vivarium. Animals were housed five per cage (59 × 38.5 × 20 cm3) for the entire duration of the experiments and they were moved to a different cage or apparatus only for the time required for the behavioral manipulation. They were kept in an environment maintained at a constant temperature and humidity, with free access to food and water. A 12 h inverted light/dark cycle (7:00 am lights off, 7:00 pm on) was used. Experiments were carried out from 9:00 am to 5:00 pm under a red light and controlled noise conditions in a testing room separated from and adjacent to the main animal room, under the same conditions of temperature and humidity. Rats were allowed at least 1 week of habituation to the animal colony and when experimental procedures began they weighed 200–225 g. The procedures used in this study are in strict accordance with the European legislation on the use and care of laboratory animals (EEC no. 86/609), with the guidelines of the National Institutes of Health on the use and care of laboratory animals, and had the approval of the local Ethics Committee.
Chronic Escape Deficit
Apparatus.
A dark Plexiglas cage (30 × 60 × 30 cm3) with a floor fitted with stainless-steel rods spaced 1 cm apart was divided into two equal chambers by a dark partition with a 10 × 10 cm2sliding door. One compartment was connected to a S48 Grass stimulator (Grass Instrument, Astro-Med Inc., West Warwick, RI, USA) (electrified chamber), while the other was disconnected from it (neutral chamber).
Procedure.
The experimental procedure, previously described in detail (Gambarana et al, 2001), consisted of exposure to unavoidable stress (pretest) followed by an escape test. Briefly, rats were immobilized with a flexible wire-net, an electrode was applied to the distal third of the tail, and about 80 electric shocks (1 mA × 5 s, 1 every 30 s) were administered; 24 h later, rats were tested in a shock-escape paradigm in the Plexiglas cage. The number of escapes out of 30 trials was recorded. Rats selected on the basis of their failure to escape (0–3 escapes/30 trials), starting 48 h after the escape test: (1) were restrained for 10 min; (2) received 10 min of restraint plus four unavoidable shocks, 48 h after (1); (3) spent 20 min in the cage where the unavoidable shock had previously been administered, 48 h after (2). By repeating this procedure on alternate days, the escape deficit can be maintained in all rats (De Montis et al, 1995). No significant differences in the amount of daily food and water consumption or in the curve of body weight increase was ever observed between control and chronically stressed rats (data not shown).
Induction of VS-Sustained Appetitive Behavior (VAB)
Apparatus.
Two dark Plexiglas boxes (box 1 and 2) were separated by a 10 × 10 cm2 sliding door. Box 2 formed the straight arm of a Y-maze (15 × 40 × 20 cm3 for each of the three arms). A VS pellet used as a reinforcer was placed at the end of one of the two divergent arms of the maze. VS pellets were made daily: standard food pellets were crushed by mortar and pestle, the fragments dampened with water and rolled in VS to obtain regular pellets weighing approximately 150 mg.
Training procedure.
The experimental procedure was previously described in detail (Ghiglieri et al, 1997). The day before the first training session, rats were allowed a first run in the Y-maze with one of the two arms closed. Each animal was placed in box 1 and 10 s later a 5 s cue-light signaled the opening of the sliding door. Rats were given 2 min to enter box 2 and to reach the end of the open arm where a VS pellet was earned. Training sessions began 24 h later.
-
1
Training sessions 1–3: The rat was placed in box 1 and the cue-light signaled the opening of the sliding door. If the rat did not enter box 2 within 60 s, it was returned to the home cage for 15 min. If it entered box 2, it was allowed 60 s to reach the end of one of the two diverging arms. Either the right or the left arm was designated correct, balanced among the animals. If the empty arm was chosen, the rat was returned to the home cage for 15 min before the next trial. When the baited arm was chosen, the rat was allowed to consume the VS pellet and then returned to the home cage for 15 min before the next trial.
-
2
The two time periods (time to leave box 1 and time to reach the end of an arm) were progressively reduced throughout training sessions and at session 10 they were fixed at 10 and 20 s, respectively.
One training session was administered every other day. Each rat underwent a total of 10 complete trials for each session, at 15 min intervals. A trained rat consistently made 6–8 correct runways out of 10 trials at each session, and this ratio of correct responses was reached within 10 sessions. In the remaining 2–4 trials rats did not necessarily reach the end of the nonbaited arm. At the end of the training, when a steady level of correct responding was obtained, rats were tested in the Y-maze according to the protocol described in (2) and their final score (number of correct runways out of 10 trials) was recorded.
Microdialysis Procedure
Anaesthetized rats (pentobarbital 50 mg/kg, scopolamine 0.4 mg/kg, i.p.) were placed in a stereotaxic instrument and two concentric vertical probes were lowered into the NAcS (AP +1.7 mm, L ±1.2 mm, V −8.0 mm) and the mPFC (AP +3.7 mm, L ±0.7 mm, V −5.0 mm), according to Paxinos and Watson (1986). Concentric microdialysis probes were made from semipermeable dialysis tubing (ID: 0.22 mm; OD: 0.31 mm; AN 69, Hospal, Bologna, Italy). The length of the permeable portion of the membrane was 2.0 mm for the NAcS, and 3.0 mm for the mPFC. The probes were fixed to the skull with stainless-steel screws and dental cement, and the skin was sutured. After surgery, the animals were housed individually in a microdialysis Plexiglas box (20 × 30 × 30 cm3) with a grid floor and an open top, and 24 h of recovery and habituation to the chamber were allowed before the beginning of microdialysis. On the day of the experiment, Ringer solution (147 mM NaCl, 2.2 mM CaCl2, 4 mM KCl) was infused at a flow rate of 1 μl/min through the probe. After a 2 h equilibration period, dialysate samples were collected every 15 min (NAcS) or every 25 min (mPFC). The 4–5 consecutive samples that showed variations in DA concentrations ⩽10% were utilized to estimate basal levels.
Dialysate samples were immediately analyzed by reverse-phase High Performance Liquid Chromatography (HPLC) with electrochemical detection. DA was eluted on a C-18 reverse phase column (Supelco LC18 DB). The detector was an ESA Coulochem II with a 5014 analytical cell. The potential of the first electrode was set at +175 mV, and that of the second electrode at −175 mV. The mobile phase consisted of an aqueous solution containing: 33 mM NaH2PO4, 0.1 mM Na2EDTA, 1 mM sodium dodecyl sulfate, 20% methanol (vol/vol) and 15% acetonitrile (vol/vol), pH 5.7. A flow-rate of 1.0 ml/min was used. Data were taken by PC using EZChrom 6.6 software (Scientific Software Inc., San Ramon, CA, USA) and quantified based on peak area by comparison with a standard curve run before and after each experiment.
At the end of the experiment, rats were killed to verify probe placement. Microdialysis data was utilized only when the correct placement of the probes had been microscopically confirmed on cresyl violet-stained brain sections.
Drugs
ALCAR and cocaine were dissolved in 0.9% saline and injected in a volume of 1 ml/kg rat body weight. Pentobarbital was dissolved in a mixture of 12% ethanol, 38% propylene glycol, 50% deionized/distilled water (vol/vol) and injected in a volume of 4 ml/kg rat body weight. Scopolamine was dissolved in deionized/distilled water. All chemicals were purchased from commercial sources; cocaine was purchased from SALARS (Como, Italy). ALCAR was donated by Sigma-Tau (Pomezia, Italy).
Statistical Analysis
Statistical analyses were performed on commercially available software (Instat 2.01 for Macintosh, GraphPad software Inc., San Diego, CA, USA). All data are expressed as mean±SEM. Comparisons were made by one-way analysis of variance (ANOVA), followed by post hoc Bonferroni test, when applicable (p<0.05). The increases in DA levels within each experimental group after the first and second VS presentation, and the number of escapes before and after Y-maze training were compared by paired t-test.
RESULTS
Experiment 1: Extraneuronal DA Output in the NAcS and mPFC in Rats Exposed to Stress for 7 days, with and without ALCAR Treatment
In order to study whether the ALCAR-induced increase in DA output could interfere with the disrupting effect of stress on basal DA output and on the dopaminergic response to palatable food consumption, 40 rats were divided into four groups of 10 animals each (Table 1). Two groups were handled daily for 2 days, and on day 3 they started treatment with saline (1 ml/kg, Control) or ALCAR (10 mg/kg, ALCAR) i.p. twice a day for 7 days; two groups were exposed to the pretest and escape test, then to the chronic stress protocol for 7 days while injected with saline (1 ml/kg, Stress) or ALCAR (10 mg/kg, Stress+ALCAR) i.p. twice a day. At 2 days after the last stress exposure and drug treatment, all rats were implanted with microdialysis probes in the NAcS and mPFC, and they were dialyzed the following day.
ALCAR treatment prevented the stress-induced decrease in DA basal levels in the NAcS. Analysis of data by ANOVA showed a significant difference between basal extraneuronal DA levels in experimental groups (F28,31=19.31, p<0.001). Post hoc Bonferroni's test indicated a reduction in DA basal levels in the Stress group compared to the Control and Stress+ALCAR groups (p<0.01), and the ALCAR group (p<0.001) (Figure 1a). In the mPFC, analysis of data by ANOVA showed a significant difference between basal extraneuronal DA levels in the different experimental groups (F28,31=7.509, p<0.001). Bonferroni's test indicated significantly lower DA levels in the Stress group compared to the Stress+ALCAR group (p<0.01, Figure 1b).
After the assessment of DA baseline values, each rat was presented with a small tray containing five VS pellets and given 5 min to consume them. ALCAR treatment prevented the negative effect of unavoidable stress exposure on DA response to palatable food. While rats in the Control, ALCAR, and Stress+ALCAR groups voraciously ate all the pellets in less than 5 min, rats in the Stress group showed less interest in the food and only six out of 10 of them ate at least some of the pellets within 5 min. In the Stress+ALCAR rats, the consumption of VS pellets was accompanied by an increased motility and stereotypies that lasted about 15 min. Microdialysis sample collection continued during and after food consumption. Extraneuronal DA levels increased after eating VS; when they returned to baseline, a second meal of VS pellets was presented and microdialysis samples continued to be collected. The four groups of rats showed a behavioral response to the second VS pellet presentation similar to that observed after the first presentation. In the Stress group, analysis of DA levels was performed only in rats that consumed VS pellets (n=6). Because of the significant differences between the groups in the basal values of extraneuronal DA, variations in DA levels after VS consumption were not calculated as percentage increases compared to basal values. DA output was calculated as the sum of the absolute amounts of the monoamine (measured values minus the mean basal value) in each of the four samples collected following VS consumption. In the NAcS, analysis by ANOVA indicated a significant difference between groups in DA release after the first VS consumption (F26,29=117.1, p<0.001). Bonferroni's test demonstrated that in the Control, ALCAR, and Stress+ALCAR groups, DA output was significantly higher than in the Stress group (p<0.001 for all comparisons), with significantly higher DA values in the Stress+ALCAR group than in the Control and ALCAR groups (p<0.001 for both comparisons) (Figure 2a). After the second VS consumption, analysis by ANOVA showed a significant difference in DA release between groups (F26,29=126.9, p<0.001). Bonferroni's test demonstrated that DA release was significantly higher in the ALCAR and Stress+ALCAR groups than in the Stress group (p<0.01 and p<0.001, respectively), and it was significantly higher in the Stress+ALCAR group than in the Control and ALCAR groups (p<0.001 for both comparisons) (Figure 2c). Habituation to the second presentation of VS pellets was present in the Control and ALCAR groups, as a comparison of DA release after the first and second VS meal revealed that the second response was significantly lower than the first (p<0.001 for both comparisons, paired t-test). In the mPFC, ANOVA indicated a significant difference in DA release between groups after the first VS consumption (F26,29=46.45, p<0.001). Bonferroni's test demonstrated that DA output was significantly lower in the Stress group than in the Control and Stress+ALCAR groups (p<0.01 and p<0.001, respectively); moreover, DA values were also significantly higher in the Stress+ALCAR group than in the Control and ALCAR groups (p<0.001 for both comparisons) (Figure 2b). After the second VS consumption, analysis by ANOVA showed a significant difference in DA release between groups (F26,29=65.77, p<0.001). Bonferroni's test demonstrated that DA output was significantly lower in the Stress group than in the Control, ALCAR, and Stress+ALCAR groups (p<0.001, p<0.01, and p<0.001, respectively); in the Stress+ALCAR group DA output was significantly higher than in the Control and ALCAR groups (p<0.001 for both comparisons) (Figure 2d). No statistically significant differences were observed between DA release after the first and second VS meal in any of the groups.
When baseline levels were reached, cocaine (5 mg/kg, i.p.) was administered and four samples were collected. Because of the significant differences between the groups in the basal values of extraneuronal DA, variations in DA levels after cocaine administration were not calculated as percentage increases compared to basal values, but as absolute increase (DA concentration in each sample collected following cocaine administration minus the basal value). In the NAcS, cocaine administration produced a significant variation in DA levels in all groups (repeated measures ANOVA, p<0.001 in all four groups: Control, F15,23=138.8; Stress, F15,23=16.28; ALCAR, F27,39=196.2; Stress+ALCAR, F27,39=142.0) (Figure 3a). In particular, Bonferroni's test demonstrated that cocaine administration induced in all groups a significant elevation of extraneuronal DA levels after 15 min (p<0.001 for all comparisons). However, when peak increases in DA levels were compared between groups they were significantly different (ANOVA, F28,31=89.54, p<0.001). The maximum DA increase was lower in the Stress group than in the Control, ALCAR, and Stress+ALCAR groups (p<0.001 for the three comparisons, Bonferroni's test), and it was higher in the ALCAR group than in the Control and Stress+ALCAR groups (p<0.001 for both comparisons, Bonferroni's test) (Figure 3a). In the mPFC, cocaine administration produced a significant variation in DA levels in all groups (repeated measures ANOVA, p<0.001 in all four groups: Control, F15,23=47.73; Stress, F15,23=39.75; ALCAR, F24,35=101.6; Stress+ALCAR, F27,39=84.78) (Figure 3b). In particular, Bonferroni's test demonstrated that cocaine administration induced in all groups a significant elevation of extraneuronal DA levels after 25 min (p<0.001 for all comparisons). However, when peak increases in DA levels were compared between groups they were significantly different (ANOVA, F27,30=20.05, p<0.001). The maximum DA increase was lower in the Stress group than in the Control, ALCAR, and Stress+ALCAR groups (p<0.01 compared Control group, p<0.001 compared to ALCAR, and Stress+ALCAR groups, Bonferroni's test), and it was higher in the ALCAR and Stress+ALCAR groups than in the Control group (p<0.05 for both comparisons, Bonferroni's test) (Figure 3b). DA accumulation was also calculated as the sum of the absolute amounts of the monoamine in each of the four samples collected following cocaine administration. In the NAcS, analysis of data by ANOVA indicated a significant difference between groups (ANOVA, F28,31=42.86, p<0.001). Bonferroni's test demonstrated that total DA accumulation was significantly reduced in the Stress group compared to the Control, ALCAR, and Stress+ALCAR groups (p<0.001 for all comparisons) (Figure 3c). Moreover, DA accumulation was significantly higher in the ALCAR group compared to the Control and Stress+ALCAR groups (p<0.001 for both comparisons) (Figure 3a). In the mPFC, analysis by ANOVA showed a significant difference between groups (ANOVA, F26,29=18.43, p<0.001). Bonferroni's test demonstrated that DA accumulation was significantly reduced in the Stress group compared to the Control, ALCAR, and Stress+ALCAR groups (p<0.001 for all comparisons) (Figure 3d). That is, ALCAR administration prevented the stress-induced decrease in DA output in the NAcS and mPFC.
Experiment 2: Effect of Long-Term ALCAR Treatment on VAB Acquisition and Dopaminergic Output in the NAcS of Rats Exposed to Chronic Stress
A total of 50 rats were divided into five groups of 10 animals each (Table 2). Rats in groups 1 and 2 were injected with saline (1 ml/kg, i.p.) twice a day and handled daily for the duration of the experimental protocol (Control), or they were trained in the Y-maze (VAB). Group 3 was administered ALCAR (10 mg/kg, i.p.) twice a day for 8 days, and then trained in the Y-maze while continuing ALCAR treatment (ALCAR+VAB). Groups 4 and 5 were exposed to the pretest, tested 24 h later for escape, and then exposed to the chronic stress protocol for 7 days while treated with saline (1 ml/kg, i.p., Stress+VAB) or ALCAR (10 mg/kg, i.p., Stress+ALCAR+VAB).
Effect of Long-Term ALCAR on the Acquisition of VAB in Previously Stressed Rats
After 1 week of treatment plus exposure to stress or handling, rats in the Stress+VAB, and Stress+ALCAR+VAB groups presented a clearcut escape deficit (Table 3). Analysis of the number of escapes by ANOVA, followed by Bonferroni's test, demonstrated a significantly lower score in the Stress+VAB, and Stress+ALCAR+VAB groups compared to the VAB and ALCAR+VAB groups (F28,31=286.58, p<0.001; Bonferroni's test p<0.001 for all four comparisons).
On day 9, 24 h after the escape test, groups 2–5 began training in the Y-maze while continuing their treatment. At the end of the training protocol (day 30), performance in the Y-maze was assessed. Rats exposed to chronic stress (Stress+VAB) did not acquire the appetitive behavior (Figure 4). Rats treated with ALCAR during stress exposure and during Y-maze training plus stress exposure acquired appetitive behavior as efficiently as the rats in the VAB group (Figure 4). Analysis of data by ANOVA showed a significant difference between group scores (F36,39=29.796, p<0.001). Bonferroni's test demonstrated that the number of correct choices was significantly lower in the Stress+VAB group than in the VAB, ALCAR+VAB, and Stress+ALCAR+VAB groups (p<0.001 for all comparisons) (Figure 4).
The day after the Y-maze test (day 31) all groups were again tested for escape. Rats in the Stress+VAB group presented a clearcut escape deficit, whereas animals treated with ALCAR showed a complete reversal of the stress-induced avoidance deficit (Table 3). Analysis of data by ANOVA followed by Bonferroni's test demonstrated a significantly lower number of escapes in the Stress+VAB group compared to the VAB, ALCAR+VAB, and Stress+ALCAR+VAB groups (F28,31=155.50, p<0.001; Bonferroni's test p<0.001 for all three comparisons).
Extraneuronal DA Output in the NAcS in Stressed Rats Trained in the Y-Maze
At 2 days after the escape test, rats from all groups were implanted with microdialysis probes in the NAcS and were dialyzed 24 h later (day 34). Rats trained in the Y-maze while exposed to stress showed a DA output in the NAcS significantly lower than that of control animals, and ALCAR treatment completely antagonized this effect. Analysis of data by ANOVA showed a significant difference between the basal extraneuronal DA levels in the different experimental groups (F35,39=108.42, p<0.001). Bonferroni's test demonstrated a significant decrease in DA basal levels in the Stress+VAB group compared to the Control, VAB, ALCAR+VAB, and Stress+ALCAR+VAB group values (p<0.001 for all comparisons). Moreover, rats in the ALCAR+VAB group had significantly higher basal levels of extraneuronal DA than those of the Stress+ALCAR+VAB group (p<0.01), while they were significantly lower than those of the VAB group (p<0.001) (Figure 5a). DA accumulation was calculated as described above as the sum of the absolute amounts of the monoamine in each of the four samples collected following cocaine administration (5 mg/kg, i.p.). Analysis of data by ANOVA indicated a significant difference between groups (ANOVA, F35,39=615.84, p<0.001). Bonferroni test demonstrated that DA accumulation was lower in the Stress+VAB group than in the Control, VAB, ALCAR+VAB, and Stress+ALCAR+VAB groups (p<0.001 for all comparisons) (Figure 5b). Moreover, DA accumulation was significantly higher in the VAB and ALCAR+VAB groups than in the Control and Stress+ALCAR+VAB groups (p<0.001 for all comparisons) (Figure 5b).
DISCUSSION
The present study shows that rats stressed for 7 days had only a meager interest in VS pellets and that only six out of 10 of them consumed the VS meal twice. In these rats, the increase in DA output after VS consumption did not reach significance in the NAcS, and it was significantly lower than that of Control rats in the mPFC. This condition is reminiscent of that of rats exposed to the chronic mild stress (CMS) procedure, a model of depression induced by chronic sequential exposure to a variety of mild stressors (Willner, 1997). CMS exposure produces decreased drinking of a sweetened solution (Willner, 1997) and reduced DA response to palatable food consumption in mesolimbic areas (Di Chiara and Tanda, 1997). Moreover, both these experimental models reduce the motivation elicited in rats by a palatable food, as chronic stress exposure prevents the acquisition of VAB (Ghiglieri et al, 1997), and CMS inhibits palatable food-induced place preference (Papp et al, 1991). Repeated ALCAR administration consistently antagonized the effects of chronic stress exposure on VS consumption, as rats in the Stress+ALCAR group showed basal DA levels similar to those of Control rats, and, when presented twice with VS meals, they quickly ate all the pellets. VS consumption in these animals was accompanied by an increase in extraneuronal DA in the mPFC and NAcS two to three times higher than that observed in the Control and ALCAR groups, and this dopaminergic response was associated with a short-lived increase in motility and intense stereotypies. Moreover, no habituation was observed in the DA response to a second VS meal in the NAcS of Stress+ALCAR rats, at variance with Control and ALCAR rats. A lack of habituation in the NAcS dopaminergic response to repeated palatable food consumption was reported in food-deprived rats, as the state of necessity strengthens the dopaminergic response (Bassareo and Di Chiara, 1999b). Thus, the daily administration of ALCAR, initiated after exposure to pretest and escape test, counteracted the stress-induced decrease in DA output and strengthened the dopaminergic response to VS in the Stress+ALCAR rats. After cocaine administration, rats in the Stress+ALCAR group showed DA accumulation values in the mPFC and NAcS similar to those of Control rats, and lower than those of the ALCAR group, selectively in the NAcS. The acute inhibition of the monoamine transporter produced by cocaine, which does not interfere with monoamine release (Di Chiara and Imperato, 1988; Hurd and Ungerstedt, 1989), induces an extraneuronal accumulation of monoamines proportional to the amount taken up by nerve terminals, and it can be used as an indicator of monoaminergic neuronal activity (Gambarana et al, 1999a,1999b).
In the second part of the study, we tested whether the increase in DA output in the mPFC and NAcS observed in the Stress+ALCAR group in response to VS consumption was predictive of the capability of rats exposed to unavoidable stress and treated with ALCAR to learn VAB. Training in the Y-maze was initiated after 7 days of chronic stress exposure and ALCAR treatment, that is, in a condition of intense dopaminergic responsiveness to VS consumption (see the Stress+ALCAR group in experiment 1). At the end of the training procedure, Stress+ALCAR+VAB rats had acquired VAB and they performed as efficiently in the Y-maze as control animals (VAB group). Moreover, in contrast with Stress+VAB rats, when tested for escape they showed a complete reversal of the avoidance deficit. That is, ALCAR treatment enabled stressed rats to learn the appetitive behavior and, in turn, VAB acquisition seemed to strengthen the protective effect of ALCAR in the development of escape deficit. The finding that VAB acquisition coincided with the recovery of avoidance competence was not completely unexpected, as rats chronically treated with lithium show an avoidance deficit similar to that of chronically stressed rats (Gambarana et al, 1999b), which disappears as a consequence of VAB acquisition (Masi et al, 2000). Thus, repeated exposure to a hedonic stimulus, contingently rewarding a specific behavioral pattern, induces the development of a motivated behavior in rats chronically treated with lithium or exposed to stress while treated with ALCAR. The development of motivated behavior in these animals is accompanied by the reversal of the avoidance deficit sustained either by lithium or by stress exposure. When dialyzed at the end of Y-maze training, VAB and ALCAR rats showed a DA output twice as high as that of Control animals. The Stress+VAB group (ie rats that had been exposed to chronic stress for 30 days and had not acquired VAB) showed a DA output in the NAcS as low as that observed after the 7-day stress exposure in experiment 1. Rats in the Stress+VAB+ALCAR group had extraneuronal DA values similar to those of Control rats. Thus, VAB acquisition during ALCAR treatment not only reverted the chronic stress-sustained escape deficit, but it also prevented the decrease in DA output in the NAcS.
The role of DA in reward-related learning has been studied in different brain areas by using elaborated behavioral models and discrete brain lesions (Beninger, 1983; Di Chiara, 1995; Montague et al, 1996; Berridge and Robinson, 1998; Packard and Knowlton, 2002; Cardinal et al, 2002). Activation of the mesolimbic DA system, as quantified by electrophysiological, microdialysis, or voltammetric measures, can be triggered in animals by encounters with food, sex, drugs of abuse, and by secondary reinforcers of these incentives (Apicella et al, 1991; Blackburn et al, 1989; Fiorino et al, 1997; Kiyatkin and Gratton, 1994; Kiyatkin and Rebec, 1997; Kiyatkin and Stein, 1996; Mark et al, 1994; Mirenowicz and Schultz, 1996; Phillips et al, 1993; Schultz et al, 1992,1997). As each of these incentives can induce the acquisition of instrumental behaviors aimed at earning and/or consuming it, an increase in DA release in the NAcS has been associated with reward and reinforcement (Beninger and Miller, 1998; Hernandez and Hoebel, 1988; Kelley and Delfs, 1991; Kiyatkin, 1995; Nader et al, 1997; Robbins et al, 1989; Robbins and Everitt, 1996; Di Chiara, 1998). DA release in the mesolimbic system was initially correlated with the hedonic properties of reward (Wise, 1982), a hypothesis presently revised to include the incentive-motivational component of reward (Wise, 1982; Berridge and Robinson, 1998; Di Chiara, 1995; Robbins and Everitt, 1992, 1996). In a model of conditioned taste aversion, DA release in the NAcS in response to an unfamiliar taste was correlated to the formation and consolidation of a gustatory short-term memory trace, the duration of which is crucial in associating a taste with a possible incoming postingestive change (Fenu et al, 2001). This effect is mediated by DA D1 receptor stimulation, as the systemic or local administration of selective antagonists prevents the development of conditioned taste aversion when the conditioned taste stimulus is associated with an unconditioned aversive stimulus, such as i.p. lithium administration (Fenu et al, 2001). As the systemic administration of DA D1 receptor antagonists also prevents the acquisition of palatable food-induced conditioned place preference (Acquas and Di Chiara, 1994), it was concluded that DA in the NAcS enables the association between a perceived taste and its biological outcome; thus, it facilitates the learning of either appetitive or aversive behaviors (Fenu et al, 2001). In searching for a role of mesolimbic DA in VAB acquisition, we observed that rats that have acquired VAB consistently show a significant increase in both the basal levels and the cocaine-induced accumulation of extraneuronal DA in the NAcS (Masi et al, 2001). When VAB-competent rats are exposed to chronic stress while continuing the training, they maintain a high frequency of correct choices in the Y-maze (Masi et al, 2001). Moreover, they show a NAcS DA output similar to that of control animals, and higher than that of chronically stressed rats; yet they rapidly develop escape deficit (Masi et al, 2001). Thus, we hypothesized that DA output in the NAcS could play a role in the acquisition and maintenance of an appetitive behavior, while the expression of a deficit in avoidance appears to be independent of it (Masi et al, 2001). However, this hypothesis was in contrast with the observation that lithium-treated rats have a markedly reduced DA output in the NAcS, but they rapidly acquire VAB (Masi et al, 2000). Rats treated with ALCAR during chronic stress exposure showed a DA output in the mPFC and NAcS and a capacity to learn VAB unmodified compared to control animals, and a DA response to VS consumption significantly higher than control animals. These results underscore the relevance of the phasic dopaminergic response to VS consumption as a predictive element of a rat's competence to learn VAB; accordingly, only rats that showed an increased extraneuronal DA output in the mPFC and NAcS in response to VS consumption acquired VAB. Microdialysis experiments on the DA response to VS ingestion and training in the Y-maze were conducted in rats that had not been previously exposed to VS. We may, therefore, assume that DA output in the mesolimbic areas in response to the first VS meal increased only in the animals (Control, ALCAR, and Stress+ALCAR) competent to learn VAB. Thus, the increased release of mesolimbic DA in response to a novel palatable food seems to be a crucial step in the formation of a gustatory short-term memory trace that can be associated with an antecedent contingent behavior (present study) or with a contingent postingestive modification (Fenu et al, 2001). In our experimental conditions, the initially fortuitous daily repetition of a DA-dependent association between ingestion of palatable food and entering one of the Y-maze arms, slowly motivated rats to express an appetitive behavior aimed at earning VS. That is, DA response to VS consumption seems necessary to trigger a cascade of molecular mechanisms underpinning the associative process between a perceived taste and a closely antecedent behavioral experience, such as entering the baited arm. In conclusion, the present study shows that ALCAR, administered to stressed rats, preserved the DA response to palatable food consumption; thus, allowing stressed rats to learn VAB. Moreover, it supports the hypothesis that mesolimbic DA plays a central role in associative learning.
References
Acquas E, Di Chiara G (1994). D1 receptors blockade stereospecifically impairs the acquisition of drug-conditioned place-preference and place-aversion. Behav Pharmacol 5: 555–569.
Angelucci L, Ramacci MT (1989). Hypothalamo-pituitary-adrenocorticol function in aging: effects of acetyle-L-cornitine. In: De Simone C, Arrigoni-Martelli E (Eds), Stress, Immunity and ageing: a role for acetyle-L-carnitine. Elsevier, Amsterdam. pp 109–118.
Apicella P, Ljungberg T, Scarnati E, Schultz W (1991). Responses to reward in monkey dorsal and ventral striatum. Exp Brain Res 85: 491–500.
Bassareo V, Di Chiara G (1997). Differential influence of associa-tive and nonassociative learning mechanisms on the responsiveness of prefrontal and accumbal dopamine transmission to food stimuli in rats fed ad libitum . J Neurosci 17: 851–861.
Bassareo V, Di Chiara G (1999a). Differential responsiveness of dopamine transmission to food-stimuli in nucleus accumbens shell/core compartments. Neuroscience 89: 637–641.
Bassareo V, Di Chiara G (1999b). Modulation of feeding-induced activation of mesolimbic dopamine transmission by appetitive stimuli and its relation to motivational state. Eur J Neurosci 11: 4389–4397.
Beninger RJ (1983). The role of dopamine in locomotor activity and learning. Brain Res Rev 6: 173–196.
Beninger RJ, Miller R (1998). Dopamine D-1 like receptors and reward-related incentive learning. Neurosci Biobehav Rev 22: 335–345.
Beninger RJ, Phillips AG (1980). The effect of pimozide on the establishment of conditioned reinforcement. Psychopharmacology 68: 147–158.
Berridge KC, Robinson TE (1998). What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience? Brain Res Rev 28: 309–369.
Bidzinska B, Petraglia F, Angioni S, Genazzani AD, Criscuolo M, Flcarra G et al. (1993). Acetyle-L-carnitine effect on pituitary and plasma b-endorphin responsiveness to different chronic intermittent stressors. J Neuroendocrinol 5: 151–155.
Bieber LL (1988). Carnitine. Annu Rev Biochem 57: 261–283.
Blackburn JR, Phillips AG, Jakubovic A, Fibiger HC (1989). Dopamine and preparatory behavior: II. A neurochemical analysis. Behav Neurosci 103: 15–23.
Calvani M, Carta A (1991). Clues to the mechanism of action of acetyl-L-carnitine in the central nervous system. Dementia 2: 1–6.
Cardinal RN, Parkinson JA, Everitt BJ (2002). Emotion and motivation: the role of the amygdala, ventral striatum, and prefrontal cortex. Neurosci Behav Rev 26: 326–352.
Cha YS, Sachan DS (1995). Acetylcarnitine mediated inhibition of ethanol oxidation in hepatocites. Alcohol 12: 289–294.
De Montis MG, Gambarana C, Ghiglieri O, Tagliamonte A (1995). Reversal of stable behavioural modifications through NMDA receptor inhibition in rats. Behav Pharmacol 6: 562–567.
Di Chiara G (1995). The role of dopamine inn drug abuse viewed from the perspective of its role in motivation. Drug Alcohol Depend 38: 95–137.
Di Chiara G (1998). A motivational learning hypothesis of the role of mesolimbic dopamine in compulsive drug use. J Psychopharmacol 12: 54–67.
Di Chiara G, Imperato A (1988). Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci USA 85: 5274–5278.
Di Chiara G, Tanda G (1997). Blunting of reactivity of dopamine transmission to palatable food: a biochemical marker of anhe-donia in the CMS model? Psychopharmacology 134: 351–353.
Di Chiara G, Tanda G, Frau R, Carboni E (1993). On the preferential release of dopamine in the nucleus accumbens by amphetamine: further evidence obtained by vertically implanted concentric microdialysis probes. Psychopharmacology 112: 398–402.
Fenu S, Bassareo V, Di Chiara G (2001). A role for dopamine D1 receptors of the nucleus accumbens shell in conditioned taste aversion learning. J Neurosci 21: 6897–6904.
Fiorino DF, Coury A, Phillips AG (1997). Dynamic changes in nucleus accumbens dopamine efflux during the Coolidge effect in male rats. J Neurosci 17: 4849–4855.
Foreman PJ, Perez-Polo JR, Angelucci L, Ramacci MT, Taglialatela G (1995). Effects of acetyl-L-carnitine treatment and stress exposure on the nerve growth factor receptor (p75NGFR) mRNA level in the central nervous system of aged rats. Prog Neuropsychopharmacol Biol 19: 117–133.
Fritz IB (1963). Carnitine and its role in fatty acid metabolism. Adv Lipid Res 1: 285–333.
Gambarana C, Ghiglieri O, Masi F, Scheggi S, Tagliamonte A, De Montis MG (1999b). The effects of long-term administration of rubidium or lithium on reactivity to stress and on dopamine output in the nucleus accumbens in rats. Brain Res 826: 200–209.
Gambarana C, Masi F, Tagliamonte A, Scheggi S, Ghiglieri O, De Montis MG (1999a). A chronic stress which impairs reactivity in rats also decreases dopaminergic transmission in the nucleus accumbens: a microdialysis study. J Neurochem 72: 2039–2046.
Gambarana C, Scheggi S, Tagliamonte A, Tolu P, De Montis MG (2001). Animal models for the study of antidepressant activity. Brain Res Prot 7: 11–20.
Ghiglieri O, Gambarana C, Scheggi S, Tagliamonte A, Willner P, De Montis MG (1997). Palatable food induces an appetitive behaviour in satiated rats which can be inhibited by chronic stress. Behav Pharmacol 8: 619–628.
Hernandez L, Hoebel BG (1988). Food reward and cocaine increase extracellular dopamine in the nucleus accumbens as measured by microdialysis. Life Sci 42: 1705–1712.
Hurd Y, Ungerstedt U (1989). Cocaine: an in vivo microdialysis evaluation of its acute action on dopamine transmission in rat striatum. Synapse 3: 48–54.
Kelley AE, Delfs JM (1991). Dopamine and conditioned reinforcement: I. Differential effects of amphetamine microinjections into striatal subregions. Psychopharmacology 103: 187–196.
Kidd PM (1999). A review of nutrients and botanicals in the integrative management of cognitive dysfunction. Altern Med Rev 4: 144–161.
Kiyatkin EA (1995). Functional significance of mesolimbic dopamine. Neurosci Biobehav Rev 19: 573–598.
Kiyatkin EA, Gratton A (1994). Electrochemical monitoring of extracellular dopamine in nucleus accumbens of rats lever-pressing for food. Brain Res 652: 225–234.
Kiyatkin EA, Rebec GV (1997). Activity of presumed dopamine neurons in the ventral tegmental area during heroin self-administration. Neuroreport 8: 2581–2585.
Kiyatkin EA, Stein EA (1996). Conditioned changes in nucleus accumbens dopamine signal established by intravenous cocaine in rats. Neurosci Lett 211: 73–76.
Liu J, Atamna H, Kuratsune H, Ames BN (2002). Delaying brain mitochondrial decay and aging with mitochondrial antioxidants and metabolites. Ann NY Acad Sci 959: 133–166.
Mangiavacchi S, Masi F, Scheggi S, Leggio B, De Montis MG, Gambarana C (2001). Long-term behavioral and neurochemical effects of chronic stress exposure in rats. J Neurochem 79: 1113–1121.
Mark GP, Smith EA, Rada PV, Hoebel BG (1994). An appetitively conditioned taste elicits a preferential increase in mesolimbic dopamine release. Pharmacol Biochem Behav 48: 651–660.
Martel P, Fantino M (1996). Mesolimbic dopaminergic system activity as a function of food reward: a microdialysis study. Pharmacol Biochem Behav 53: 221–226.
Masi F, Scheggi S, Mangiavacchi S, Romeo A, Tagliamonte A, De Montis MG et al (2000). Acquisition of an appetitive behavior reverses the effects of long-term treatment with lithium in rats. Neuroscience 100: 805–810.
Masi F, Scheggi S, Mangiavacchi S, Tolu P, Tagliamonte A, De Montis MG (2001). Dopamine output in the nucleus accumbens shell is related to the acquisition and the retention of a motivated appetitive behavior in rats. Brain Res 903: 102–109.
Mirenowicz J, Schultz W (1996). Preferential activation of midbrain dopamine neurons by appetitive rather than aversive stimuli. Nature 379: 449–451.
Montague PR, Dayan P, Sejnowski TJ (1996). A framework for mesencephalic dopamine system based on predictive hebbian learning. J Neurosci 16: 1936–1947.
Nader K, Bechara A, van der Kooy D (1997). Neurobiological constraints on behavioral models of motivation. Annu Rev Psychol 48: 85–114.
Packard MG, Knowlton BJ (2002). Learning and memory functions of the basal ganglia. Annu Rev Neurosci 25: 563–593.
Papp M, Willner P, Muscat R (1991). An animal model of anhedonia: attenuation of sucrose consumption and place preference conditioning by chronic unpredictable mild stress. Psychopharmacology 104: 255–259.
Patacchioli FR, Amenta R, Ramacci MT, Taglialatela G, Maccarl S, Angelucci L (1989). Acetyl-L-carnitine reduces the age-dependent loss of glucocorticoid receptors in that rat hippocampus: an autoradiographic study. J Neurosci Res 23: 462–466.
Paxinos G, Watson C et al. (1986). The Rat Brain in Stereotaxic Coordinates. Academic Press: New York.
Phillips AG, Atkinson LJ, Blackburn JA, Blaha CD (1993). Increased extracellular dopamine in the nucleus accumbens of the rat elicited by a conditioned stimulus for food: an electrochemical study. Can J Physiol Pharmacol 71: 387–393.
Robbins TW (1978). The acquisition of responding with conditioned reinforcement: effects of pipradrol, methylphenidate, d-amphetamine, and nomifensine. Psychopharmacology 58: 79–87.
Robbins TW, Cador M, Taylor JR, Everitt BJ (1989). Limbic-striatal interactions in reward related processes. Neurosci Biobehav Rev 13: 155–162.
Robbins TW, Everitt BJ (1992). Functions of dopamine in the dorsal and ventral striatum. Semin Neurosci 4: 119–128.
Robbins TW, Everitt BJ (1996). Neurobehavioural mechanisms of reward and motivation. Curr Opin Neurobiol 6: 228–236.
Schultz W, Apicella P, Scarnati E, Ljungberg T (1992). Neuronal activity in monkey ventral striatum related to the expectation of reward. J Neurosci 12: 4595–4610.
Schultz W, Dayan P, Montague PR (1997). A neural substrate of prediction and reward. Science 275: 1593–1599.
Swamy-Mruthinti S, Carter AL (1999). Acetyl-L-carnitine decreases glycation of lens proteins in vivo studies. Exp Eye Res 69: 109–115.
Taylor JR, Robbins TW (1984). Enhanced behavioural control by conditioned reinforcers following microinjections of D-amphetamine into the nucleus accumbens. Psychopharmacology 84: 405–412.
Taylor JR, Robbins TW (1986). 6-Hydroxydopamine lesions of the nucleus accumbens, but not of the caudate nucleus, attenuate enhanced responding with reward-related stimuli produced by intra-accumbens d-amphetamine. Psychopharmacology 90: 390–397.
Tolu P, Masi F, Leggio B, Scheggi S, Tagliamonte A, De Montis MG et al (2002). Effects of long-term acetyl-L-carnitine administration in rats: I. Increased dopamine output in mesocorticolimbic areas and protection toward acute stress exposure. Neuropsychopharmacology 27: 410–420.
Willner P (1997). Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation. Psychopharmacology 134: 319–329.
Wise RA (1982). Neuroleptics and operant behavior: the anhedonia hypothesis. Behav Brain Sci 5: 39–87.
Acknowledgements
This research was supported by a grant from the University of Siena (PAR 2000). We thank Ms Colleen Pisaneschi for editing the manuscript and Sigma-Tau (Pomezia, Italy) for the gift of acetyl-L-carnitine.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Masi, F., Leggio, B., Nanni, G. et al. Effects of Long-Term Acetyl-L-Carnitine Administration in Rats—II: Protection Against the Disrupting Effect of Stress on the Acquisition of Appetitive Behavior. Neuropsychopharmacol 28, 683–693 (2003). https://doi.org/10.1038/sj.npp.1300078
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.npp.1300078